Macular Edema Due to Retinal Vein Occlusion

• CLINICAL_TRIALS trial_result · 2025-03-21
  Clinical Trial Update: Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy [Phase 2]

  Phase 2 study assessing the safety and efficacy of the IBE-814 dexamethasone intravitreal implant for diabetic macular edema and macular ede…

• CLINICAL_TRIALS trial_result · 2022-03-22
  Clinical Trial Update: Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions [Phase 2]

  Phase 2 trial evaluating combined intravitreal bevacizumab with oral acetazolamide versus intravitreal bevacizumab alone for macular edema d…

• CLINICAL_TRIALS trial_result · 2021-07-02
  Clinical Trial Update: Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) [Phase 2]

  Phase 2 trial update for AR-1105 in macular edema due to retinal vein occlusion has completed with results posted.

• FDA approval · 2020-10-21
  FDA Approved: OZURDEX — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for OZURDEX (dexamethasone) by Allergan, Inc.

• CLINICAL_TRIALS trial_result · 2015-06-08
  Clinical Trial Update: Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) [Phase 3]

  Phase 3 trial assessing dexamethasone for macular edema after retinal vein occlusion has completed with results posted in 2015.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.